Additionally to the concerns about vaccine lipid nanoparticles accumulating in ovaries, try this paper from 2012.

https://www.sciencedirect.com/science/article/abs/pii/S0168365912000892?via%3Dihub

So, NINE YEARS before selecting that formulation for the Pfizer & the Moderna mRNA vaccines, it was well-known to the expert formulation community that formulations of this kind DO accumulate in ovaries.

In case you’re not convinced, here’s the title if that paper: “Accumulation of nanocarriers in the ovary: A neglected toxicity risk?”

It’s just a little bit...damning, isn’t it?